These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27586204)

  • 21. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
    Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
    Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
    Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
    Saito T; Niida A; Uchi R; Hirata H; Komatsu H; Sakimura S; Hayashi S; Nambara S; Kuroda Y; Ito S; Eguchi H; Masuda T; Sugimachi K; Tobo T; Nishida H; Daa T; Chiba K; Shiraishi Y; Yoshizato T; Kodama M; Okimoto T; Mizukami K; Ogawa R; Okamoto K; Shuto M; Fukuda K; Matsui Y; Shimamura T; Hasegawa T; Doki Y; Nagayama S; Yamada K; Kato M; Shibata T; Mori M; Aburatani H; Murakami K; Suzuki Y; Ogawa S; Miyano S; Mimori K
    Nat Commun; 2018 Jul; 9(1):2884. PubMed ID: 30038269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational Heterogeneity in
    Gausachs M; Borras E; Chang K; Gonzalez S; Azuara D; Delgado Amador A; Lopez-Doriga A; San Lucas FA; Sanjuan X; Paules MJ; Taggart MW; Davies GE; Ehli EA; Fowler J; Moreno V; Pineda M; You YN; Lynch PM; Lazaro C; Navin NE; Scheet PA; Hawk ET; Capella G; Vilar E
    Clin Cancer Res; 2017 Oct; 23(19):5936-5947. PubMed ID: 28645942
    [No Abstract]   [Full Text] [Related]  

  • 25. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
    Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
    Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
    Zauber P; Marotta S; Sabbath-Solitare M
    BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.
    Tanabe H; Moriichi K; Takahashi K; Ono Y; Kobayashi Y; Murakami Y; Iwama T; Kunogi T; Sasaki T; Ando K; Ueno N; Kashima S; Takei H; Mizukami Y; Fujiya M; Okumura T
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1348. PubMed ID: 32543103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.
    Xu XM; Qian JC; Cai Z; Tang T; Wang P; Zhang KH; Deng ZL; Cai JP
    Eur J Clin Invest; 2012 Jul; 42(7):751-9. PubMed ID: 22324744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
    Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
    Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma.
    Amin A; Murati-Amador B; Lombardo KA; Jackson CL; Grada Z; Palsgrove DN; Matoso A
    Appl Immunohistochem Mol Morphol; 2020; 28(10):786-790. PubMed ID: 31876604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity.
    Woischke C; Jung P; Jung A; Kumbrink J; Eisenlohr S; Auernhammer CJ; Vieth M; Kirchner T; Neumann J
    J Pathol Clin Res; 2021 Jan; 7(1):75-85. PubMed ID: 33197299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study.
    Liao X; Hao Y; Zhang X; Ward S; Houldsworth J; Polydorides AD; Harpaz N
    PLoS One; 2019; 14(2):e0212142. PubMed ID: 30730996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
    Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
    Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
    Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct molecular features of different macroscopic subtypes of colorectal neoplasms.
    Konda K; Konishi K; Yamochi T; Ito YM; Nozawa H; Tojo M; Shinmura K; Kogo M; Katagiri A; Kubota Y; Muramoto T; Yano Y; Kobayashi Y; Kihara T; Tagawa T; Makino R; Takimoto M; Imawari M; Yoshida H
    PLoS One; 2014; 9(8):e103822. PubMed ID: 25093594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
    Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
    Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.
    Qiu Y; Fu X; Zhang W; Xu Y; Xiao L; Chen X; Shi L; Zhou X; Xia G; Peng Y; Deng M
    J Clin Pathol; 2014 Jun; 67(6):491-8. PubMed ID: 24570042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
    Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.